Sandoz Group AG
SDZ
株式のランク
#581
Operating globally, Sandoz Group AG specializes in the development, production,... Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities. Sandoz is also a significant player in the biotechnology sector, providing protein-based products such as biosimilars and offering specialized manufacturing services within this field. Furthermore, it supplies anti-infective products, including active pharmaceutical ingredients (APIs) and intermediates, with a strong emphasis on antibiotics. Established in 1886, Sandoz maintains its headquarters in Rotkreuz, Switzerland.
株価
$96.01
時価総額
$41.54B
変化（1日）
0.82%
変化（1年）
58.65%
国
CH
取引 Sandoz Group AG (SDZ)
カテゴリー
Healthcare
Sandoz Group AG（SDZ）の利益
2026 時点の利益 TTM: 0
Sandoz Group AG の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Sandoz Group AG の利益の推移（2020 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2025 | $1.21B | -11,072.73% |
| 2024 | $-11.00M | -108.46% |
| 2023 | $130.00M | -88.20% |
| 2022 | $1.10B | -15.20% |
| 2021 | $1.30B | 85.42% |
| 2020 | $700.85M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | - |
IN
|
